Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of V-MPT Versus V-MP in Elderly Untreated Multiple Myeloma Patients
2005-004745-33Phase 3Active
- Sponsor
- Fondazione EMN Italy
- Start
- Mar 2007
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bortezomib in multiple myeloma (MM) (2 arms), sponsored by Fondazione EMN Italy. Started Mar 2007; status: active.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-004745-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004745-33.